Development of pharmacovigilance system in Ukraine: first results

被引：6
|
作者：
Stefanov, O [1 ]
Sharayeva, M [1 ]
Jajtchenja, V [1 ]
机构：
[1] Minist Hlth Ukraine, State Pharmacol Ctr, Kiev, Ukraine
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2004年 / 13卷 / 03期
关键词：
adverse drug events/reactions; medicinal product/drug; pharmacovigilance;
D O I：
10.1002/pds.886
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The article is devoted to the establishment and development of the National Pharmacovigilance system in Ukraine. A drug safety centre of Ukraine started to form a pharmacovigilance system in 1996. It has been operating on a regular basis since 2000 and now provides the regulatory services that include data collection and analysis, database management, education, international contacts, and the publication and dissemination of information. Our ultimate goal is to foster a rational and safe drug use and to improve the quality of pharmacotherapy in Ukraine. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码：197 / 199
页数：3
相关论文
共 50 条
  • [41] High Anti-Corruption Court of Ukraine: the peculiarities of establishment and the first results
    Drozd, Oleksii
    Nykytiuk, Yaroslav
    Dorofeieva, Liliia
    Andriiko, Olha
    Sabluk, Serhii
    [J]. AMAZONIA INVESTIGA, 2020, 9 (29): : 170 - 178
  • [42] Hospital information system-based pharmacovigilance for elderly patients: practices and results
    Zhou, Nan
    Fang, Zhiyuan
    Liang, Dong
    Lian, Jiangping
    Han, Huan
    Li, Rui
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (03) : 525 - 532
  • [43] DEVELOPMENT OF A NEW LOW-COST INDOOR MAPPING SYSTEM - SYSTEM DESIGN, SYSTEM CALIBRATION AND FIRST RESULTS
    Kersten, T. P.
    Stallmann, D.
    Tschirschwitz, F.
    [J]. XXIII ISPRS CONGRESS, COMMISSION V, 2016, 41 (B5): : 55 - 62
  • [44] The Pharmacovigilance System in India
    Nilima Kshirsagar
    [J]. Drug Safety, 2005, 28 : 647 - 650
  • [45] Development of Guideline and Macro Flow for Brazilian System of Pharmacovigilance: Basis for Decentralization
    M. O. Bittencourt
    M. F. Dias
    P. M. Figueiredo
    F. C. S. Cruz
    [J]. Drug Safety, 2008, 31 : 885 - 885
  • [46] Development, Validation and Implementation of an Active Electronic Pharmacovigilance System in Hospitalized Patients
    Ceschi, A.
    Hitz, P.
    Mueller, L.
    Bertoli, R.
    Piffaretti, V.
    [J]. DRUG SAFETY, 2018, 41 (11) : 1194 - 1195
  • [47] Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations
    Peters, Tanja
    Soanes, Nigel
    Abbas, Maya
    Ahmad, Jabeen
    Delumeau, Jean-Christophe
    Herrero-Martinez, Esteban
    Paramananda, Melanie
    Piper, Johanna
    Smail-Aoudia, Fairouz
    van der Spuij, Willemijn
    Veizovic, Tina
    Winstanley, Gillian
    [J]. DRUG SAFETY, 2021, 44 (01) : 17 - 28
  • [48] Pharmacovigilance and Patient Safety - Results of the German Net of Regional Pharmacovigilance Centers
    Hosford, J.
    Rottenkolber, M.
    Szymanski, J.
    Mueller, S.
    Haase, G.
    May, K.
    Guenther, I. R.
    Hippius, M.
    Thuermann, P. A.
    [J]. DRUG SAFETY, 2008, 31 (10) : 918 - 918
  • [49] Pharmacovigilance and Patient Safety — Results of the German Net of Regional Pharmacovigilance Centers
    J. Hasford
    M. Rottenkolber
    J. Szymanski
    S. Mueller
    G. Haase
    K. May
    I. R. Guenther
    M. Hippius
    P. A. Thuermann
    [J]. Drug Safety, 2008, 31 : 885 - 885
  • [50] The pharmacovigilance system in India
    Kshirsagar, N
    [J]. DRUG SAFETY, 2005, 28 (07) : 647 - 650
12345